A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis - PubMed (original) (raw)
Clinical Trial
A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis
M Basaranoglu et al. J Hepatol. 1999 Aug.
No abstract available
Comment on
- Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance.
James OF, Day CP. James OF, et al. J Hepatol. 1998 Sep;29(3):495-501. doi: 10.1016/s0168-8278(98)80073-1. J Hepatol. 1998. PMID: 9765002 Review. No abstract available.
Similar articles
- Gemfibrozil effectively lowers protease inhibitor-associated hypertriglyceridemia in HIV-1-positive patients.
Hewitt RG, Shelton MJ, Esch LD. Hewitt RG, et al. AIDS. 1999 May 7;13(7):868-9. doi: 10.1097/00002030-199905070-00023. AIDS. 1999. PMID: 10357393 No abstract available. - Conclusions from the VA-HIT study.
Rubins HB, Robins SJ. Rubins HB, et al. Am J Cardiol. 2000 Sep 1;86(5):543-4. doi: 10.1016/s0002-9149(00)01010-9. Am J Cardiol. 2000. PMID: 11009274 No abstract available. - Effect of Andrographis paniculata Extract on Triglyceride Levels of the Patients with Hypertriglyceridemia: A Randomized Controlled Trial.
Phunikhom K, Khampitak K, Aromdee C, Arkaravichien T, Sattayasai J. Phunikhom K, et al. J Med Assoc Thai. 2015 Jul;98 Suppl 6:S41-7. J Med Assoc Thai. 2015. PMID: 26434249 Clinical Trial. - Fibrates and high-dose statins to prevent coronary heart disease events.
Jones PH. Jones PH. Curr Cardiol Rep. 1999 Sep;1(3):223-4. doi: 10.1007/s11886-999-0026-8. Curr Cardiol Rep. 1999. PMID: 10980845 Review. No abstract available. - [Helsinki Heart Study].
Sekiya M, Ishibashi S. Sekiya M, et al. Nihon Rinsho. 2001 Mar;59 Suppl 3:404-9. Nihon Rinsho. 2001. PMID: 11347103 Review. Japanese. No abstract available.
Cited by
- Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease.
Fougerat A, Montagner A, Loiseau N, Guillou H, Wahli W. Fougerat A, et al. Cells. 2020 Jul 8;9(7):1638. doi: 10.3390/cells9071638. Cells. 2020. PMID: 32650421 Free PMC article. Review. - From fatty liver to fibrosis: a tale of "second hit".
Basaranoglu M, Basaranoglu G, Sentürk H. Basaranoglu M, et al. World J Gastroenterol. 2013 Feb 28;19(8):1158-65. doi: 10.3748/wjg.v19.i8.1158. World J Gastroenterol. 2013. PMID: 23483818 Free PMC article. Review. - Treatment of non-alcoholic fatty liver disease.
Adams LA, Angulo P. Adams LA, et al. Postgrad Med J. 2006 May;82(967):315-22. doi: 10.1136/pgmj.2005.042200. Postgrad Med J. 2006. PMID: 16679470 Free PMC article. Review. - Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease.
Kallwitz ER, McLachlan A, Cotler SJ. Kallwitz ER, et al. World J Gastroenterol. 2008 Jan 7;14(1):22-8. doi: 10.3748/wjg.14.22. World J Gastroenterol. 2008. PMID: 18176957 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical